OrthoPediatrics (NASDAQ:KIDS) Shares Down 3.5% on Insider Selling

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price fell 3.5% on Wednesday following insider selling activity. The company traded as low as $24.48 and last traded at $24.54. 22,235 shares traded hands during trading, a decline of 86% from the average session volume of 162,242 shares. The stock had previously closed at $25.42.

Specifically, insider Gregory A. Odle sold 5,359 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $133,224.74. Following the transaction, the insider now directly owns 148,788 shares of the company’s stock, valued at approximately $3,698,869.68. This trade represents a 3.48 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Fred Hite sold 6,443 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $160,172.98. Following the completion of the transaction, the chief financial officer now directly owns 207,989 shares in the company, valued at approximately $5,170,606.54. This represents a 3.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In related news, CEO David R. Bailey sold 6,620 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $164,573.20. Following the transaction, the chief executive officer now directly owns 319,155 shares of the company’s stock, valued at approximately $7,934,193.30. This trade represents a 2.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Analysts Set New Price Targets

A number of equities analysts recently commented on KIDS shares. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday, March 5th. Truist Financial cut their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Finally, Stifel Nicolaus cut their price target on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a research note on Wednesday, March 5th.

OrthoPediatrics Trading Up 1.6 %

The stock has a market cap of $620.29 million, a PE ratio of -20.76 and a beta of 1.22. The stock has a 50-day moving average price of $24.84 and a two-hundred day moving average price of $25.53. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04. The firm had revenue of $52.67 million during the quarter, compared to analyst estimates of $51.16 million. OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. During the same quarter last year, the business posted ($0.23) earnings per share. Sell-side analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Millennium Management LLC purchased a new position in OrthoPediatrics in the fourth quarter worth about $9,798,000. Point72 Asset Management L.P. purchased a new position in OrthoPediatrics in the fourth quarter worth about $7,450,000. Wasatch Advisors LP grew its position in OrthoPediatrics by 47.2% in the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after acquiring an additional 223,217 shares in the last quarter. Wellington Management Group LLP grew its position in OrthoPediatrics by 20.2% in the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock worth $24,601,000 after acquiring an additional 178,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in OrthoPediatrics by 29.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after acquiring an additional 152,681 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.